Cargando…
The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension
Autores principales: | Forzano, Imma, Mone, Pasquale, Varzideh, Fahimeh, Jankauskas, Stanislovas S., Kansakar, Urna, De Luca, Antonio, Santulli, Gaetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780529/ https://www.ncbi.nlm.nih.gov/pubmed/36568122 http://dx.doi.org/10.3389/fendo.2022.1097968 |
Ejemplares similares
-
Sortilin drives hypertension by modulating sphingolipid/ceramide homeostasis and by triggering oxidative stress
por: Varzideh, Fahimeh, et al.
Publicado: (2022) -
Functional Role of microRNAs in Regulating Cardiomyocyte Death
por: Kansakar, Urna, et al.
Publicado: (2022) -
Cardiovascular Endocrinology: Evolving Concepts and Updated Epidemiology of Relevant Diseases
por: Varzideh, Fahimeh, et al.
Publicado: (2021) -
Functional Role of Taurine in Aging and Cardiovascular Health: An Updated Overview
por: Santulli, Gaetano, et al.
Publicado: (2023) -
Parkin Controls Cardiac Function in Obesity by Regulating Mitochondrial Calcium Uptake
por: Jankauskas, Stanislovas, et al.
Publicado: (2022)